BACKGROUND
Diabetes has become a severe health threat in China, owing to its increasing prevalence, long-term morbidity, and mortality.
OBJECTIVE
This study evaluated the association between adherence to blood glucose self-monitoring guidance and glycemic control among patients with T2DM A 12-week mHealth-based prospective cohort study was conducted. Patients received recommendations on self-monitoring of blood glucose (SMBG) testing frequencies and uploaded testing results through smart glucose monitoring devices. initiating basal insulin in China.
METHODS
A 12-week mHealth-based prospective cohort study was conducted. Patients received recommendations on self-monitoring of blood glucose (SMBG) testing frequencies and uploaded testing results through smart glucose monitoring devices.
RESULTS
A total of 14,084 patients from 242 hospitals were enrolled. Most patients (73.3%) had <4 times SMBG testing per week, and these patients were significantly older, mostly males, had a longer duration of diabetes, lower income and received less education than patients with better adherence. Larger HbA1c reduction was observed in patients with 4-7 and ≥7 times of SMBG testing per week compared to patients with <4 times of SMBG testing per week (LS mean difference [95% CI]: -0.10 [-0.18, -0.02], and -0.17 [-0.26, -0.08], respectively, and this was more prominent in patients with baseline HbA1c >9%. The benefit of improving adherence to SMBG guidance was consistently found for FBG reduction, HbA1c, and FBG target rate.
CONCLUSIONS
The study demonstrated a positive relationship between adherence and glycemic control and identified patient characteristics with poorer adherence for further customization of mHealth.